Back to search
FDAFDA · Food and drugs·Recall number D-0714-2022

Diclofenac Sodium Topical Solution 1.5%, 150 mL, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534 Mfg. For SOLA Pharmaceuticals Baton Rouge, LA, NDC 61919-675-05

Published March 30, 2022 · Recall initiated: December 7, 2021

Summary

FDA records drug Class II recall D-0714-2022, published March 30, 2022 and initiated December 7, 2021. Recalling firm: Direct Rx; Status: Terminated; Reported quantity: 312 bottles; Lot: Lot #: 24MA2010 Exp. 1/31/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: Leaking containers.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Direct Rx
Distributor
Nationwide within the United States
Lot
Lot #: 24MA2010 Exp. 1/31/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diclofenac Sodium Topical Solution 1.5%, 150 mL, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534 Mfg. For SOLA Pharmaceuticals Baton Rouge, LA, NDC 61919-675-05 recalled?

Yes. FDA published recall D-0714-2022 on March 30, 2022. Reported hazard: Defective Container: Leaking containers.

What should I do if I have this product?

Voluntary: Firm initiated · Letter